Attilio Bondanza
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma.
Journal: Nature
Published: February 12, 2025
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 15, 2024
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses.
Journal: Journal for immunotherapy of cancer
Published: December 10, 2022
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses.
Journal: Cell death & disease
Published: December 01, 2022
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Journal: Cancer discovery
Published: November 11, 2022
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies.
Journal: Science translational medicine
Published: January 19, 2022
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation.
Journal: Transplantation and cellular therapy
Published: July 13, 2021
Manufacturing of Human Tissues as off-the-Shelf Grafts Programmed to Induce Regeneration.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: May 17, 2021
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.
Journal: The Journal of clinical investigation
Published: April 23, 2021
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients.
Journal: Frontiers in immunology
Published: March 02, 2020
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis.
Journal: Nature communications
Published: January 22, 2020
Last Updated: 09/26/2026